TherapeuticsMD Financial Statements From 2010 to 2026

TherapeuticsMD Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 13.9 M 13.3 M 6 M Slightly volatile Total Assets 53.3 M 44.6 M 93.4 M Pretty Stable Other Current Liabilities 3.6 M 3.8 M 14 M Slightly volatile Total Current Liabilities 5.6 M 5.9 M 31.8 M Pretty Stable Property Plant And Equipment Net 7.4 M 7 M 4.1 M Slightly volatile Accounts Payable 281.9 K 296.7 K 5.6 M Very volatile Cash 5.5 M 5.8 M 56.3 M Very volatile Non Current Assets Total 34.9 M 33.2 M 21.6 M Slightly volatile Cash And Short Term Investments 5.5 M 5.8 M 56.3 M Very volatile Net Receivables 4.9 M 4.1 M 8.2 M Slightly volatile Common Stock Total Equity 519.2 K 494.5 K 275.2 K Slightly volatile Liabilities And Stockholders Equity 53.3 M 44.6 M 93.4 M Pretty Stable Inventory 9.2 M 8.8 M 4.7 M Slightly volatile Other Stockholder Equity 1.2 B 1.1 B 582.1 M Slightly volatile Total Liabilities 12.5 M 13.2 M 65.5 M Pretty Stable Property Plant And Equipment Gross 7.4 M 7 M 4.3 M Slightly volatile Total Current Assets 10.8 M 11.4 M 71.4 M Very volatile Common Stock 12 K 12.7 K 118.2 K Slightly volatile Short and Long Term Debt Total 7.8 M 8.3 M 66.9 M Very volatile Non Currrent Assets Other 4.8 M 2.8 M 5.3 M Slightly volatile Short Term Debt 1.8 M 1.9 M 12.6 M Pretty Stable Other Assets 1.09 1.15 3.2 M Very volatile Capital Surpluse 1.2 B 1.1 B 576.3 M Slightly volatile Intangible Assets 4.7 M 5 M 9 M Pretty Stable Property Plant Equipment 10.3 K 10.8 K 974.9 K Very volatile Other Liabilities 1.8 K 1.9 K 28.2 K Slightly volatile Long Term Debt Total 140.1 M 273.4 M 132.2 M Slightly volatile Non Current Liabilities Other 636.1 K 669.6 K 4.5 M Pretty Stable Net Invested Capital 23.4 M 24.6 M 103.7 M Slightly volatile Capital Stock 9.4 K 9.9 K 189.1 K Slightly volatile Capital Lease Obligations 7.1 M 6.5 M 9.6 M Slightly volatile Short and Long Term Debt 150.6 M 169.4 M 184.9 M Slightly volatile
TherapeuticsMD Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 363.7 K 585.4 K 602.1 K Slightly volatile Selling General Administrative 5.2 M 5.5 M 36.3 M Pretty Stable Total Revenue 1.9 M 2 M 17.4 M Pretty Stable Gross Profit 1.9 M 2 M 14.7 M Pretty Stable Other Operating Expenses 7.1 M 7.5 M 70 M Very volatile Cost Of Revenue 556.1 K 585.4 K 2.9 M Very volatile Total Operating Expenses 7.1 M 7.5 M 67.2 M Very volatile Selling And Marketing Expenses 1.3 M 1.4 M 54 M Very volatile Research Development 4.7 M 5 M 18.4 M Pretty Stable Reconciled Depreciation 556.1 K 585.4 K 881.6 K Slightly volatile
TherapeuticsMD Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 4.7 M 5 M 56.6 M Pretty Stable End Period Cash Flow 5.5 M 5.8 M 57 M Very volatile Depreciation 580.8 K 585.4 K 644.1 K Slightly volatile Stock Based Compensation 288.4 K 303.6 K 7 M Pretty Stable Change To Netincome 12.6 M 23.5 M 13.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 6.15 6.48 413 Slightly volatile Dividend Yield 1.0E-4 1.0E-4 1.0E-4 Slightly volatile Days Sales Outstanding 698 664 590 Slightly volatile Average Payables 19.8 M 18.9 M 12.8 M Slightly volatile Stock Based Compensation To Revenue 0.18 0.19 0.7185 Slightly volatile Capex To Depreciation 49.34 46.99 20.3996 Slightly volatile EV To Sales 7.47 7.86 423 Slightly volatile Inventory Turnover 0.2 0.21 1.5346 Slightly volatile Days Of Inventory On Hand 1.9 K 1.8 K 848 Slightly volatile Payables Turnover 0.71 0.74 1.0494 Slightly volatile Sales General And Administrative To Revenue 0.71 0.74 2.9785 Very volatile Average Inventory 1.2 M 1.2 M 1.1 M Slightly volatile Research And Ddevelopement To Revenue 0.18 0.1608 1.02 Slightly volatile Capex To Revenue 34.94 33.28 8.5172 Slightly volatile Cash Per Share 0.38 0.39 12.9281 Pretty Stable Days Payables Outstanding 383 508 659 Pretty Stable Intangibles To Total Assets 0.12 0.13 0.1114 Pretty Stable Current Ratio 2.1 2.21 4.071 Slightly volatile Receivables Turnover 0.54 0.57 7.7253 Slightly volatile Capex Per Share 4.36 4.15 1.7178 Slightly volatile Average Receivables 32.4 M 30.9 M 15.9 M Slightly volatile Revenue Per Share 0.13 0.14 3.6315 Very volatile Interest Debt Per Share 0.53 0.56 11.9619 Very volatile Debt To Assets 0.16 0.17 0.4936 Pretty Stable Graham Number 31.15 29.67 30.8314 Slightly volatile Operating Cycle 421 664 856 Pretty Stable Days Of Payables Outstanding 383 508 659 Pretty Stable Ebt Per Ebit 0.54 0.57 1.0758 Slightly volatile Long Term Debt To Capitalization 1.98 1.88 1.248 Slightly volatile Total Debt To Capitalization 0.18 0.19 0.8879 Slightly volatile Quick Ratio 2.1 2.21 3.839 Slightly volatile Net Income Per E B T 0.8 0.84 7.8234 Pretty Stable Cash Ratio 1.07 1.13 3.0576 Slightly volatile Days Of Inventory Outstanding 1.9 K 1.8 K 848 Slightly volatile Days Of Sales Outstanding 698 664 590 Slightly volatile Fixed Asset Turnover 0.25 0.26 41.1954 Slightly volatile Debt Ratio 0.16 0.17 0.4936 Pretty Stable Price Sales Ratio 6.15 6.48 413 Slightly volatile Asset Turnover 0.0496 0.0522 0.2984 Slightly volatile Gross Profit Margin 0.93 0.88 0.7938 Slightly volatile
TherapeuticsMD Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 364.4 M 383.6 M 666.8 M Slightly volatile Enterprise Value 825.9 M 576.9 M 730.3 M Slightly volatile

TherapeuticsMD Fundamental Market Drivers

TherapeuticsMD Upcoming Events

About TherapeuticsMD Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TherapeuticsMD is a strong investment it is important to analyze TherapeuticsMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TherapeuticsMD's future performance. For an informed investment choice regarding TherapeuticsMD Stock, refer to the following important reports:

How To Invest In TherapeuticsMD Details

Is TherapeuticsMD Stock a good investment? Details

What is TherapeuticsMD's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details